Dxcover Secures Funding, Expands Leadership for Growth
February 3, 2025
Dxcover Limited, a clinical-stage diagnostics company pioneering its multiomic spectral analysis (MOSA-Dx) for early detection of solid tumor cancers, has announced its next key stage